•
Sep 30, 2021

Anaptysbio Q3 2021 Earnings Report

Total Revenue
$20.9M
EPS
-$0.24
Previous year: -$0.87
-72.4%
Gross Profit
-$1.33M
Cash and Equivalents
$336M
Previous year: $209M
+60.8%
Free Cash Flow
-$7.18M
Previous year: -$17.1M
-58.0%
Total Assets
$424M
Previous year: $385M
+10.3%

Anaptysbio

Anaptysbio